UK-based biotechnology company BiologIC Technologies has won a portion of a £33 million grant program from the UK Space Agency to study how biological systems behave in low orbit and space environments, the biotech company announced on Monday.
The grant of £300,000—around $390,000—will go toward further research into space biomanufacturing. BiologIC Technologies works across a variety of fields, including developing vaccines and gene therapy techniques.
”Space biomanufacturing has become a strategic imperative for nations needing to sustain human activities in deep space and for biopharmaceutical companies generating new therapeutic value from microgravity environments,” the company said.
A decentralized autonomous organization (DAO) is taking its interest in life extension to the next level, founding a biotech company to pursue cutting-edge science in treating cancer and other age-related diseases.
VitaDAO, a community-owned collective with a mission to fund and advance early-stage longevity research, announced today the launch of Matrix Biosciences, in partnership with world-renowned biologist Vera Gorbunova. A professor at the University of Rochester, Gorbunova is credited wit...
Biomanufacturing refers to the creation of products that use living systems such as microorganisms, animal cells, or plant cells.
“Deep space—the ultimate challenge for distributed biomanufacturing,” BiologIC Technologies wrote on Twitter. “We’re excited to adapt our precision bioprocessing platform modules for semi-autonomous microgravity operation in partnership with [the UK Space Agency].”
Through its National Space Innovation Programme, the UK Space Agency is investing up to £65 million ($84 million) in projects designed by UK-based companies that develop new space technologies and services.
"It's really difficult on earth to study the effects of aging because it takes so long, but in space, our cells age faster,” BiologIC Technologies CEO Richard Vellacott told the BBC. “This kind of research can be done quicker up there and potentially speed up new treatments,"
The BBC reported that the company's technology will be tested aboard the International Space Station.
“if we can make raw materials in space, we'll start to do it on Earth,” Vellacott told the broadcaster. “At the moment we import what we don't have from other areas, which isn't sustainable in the long term.”
BiologIC Technologies did not immediately respond to a request for comment from Decrypt.
SpaceX CEO Elon Musk has frequently expressed his desire to build a colony on Mars, but how this gargantuan feat would be accomplished remains unclear. Beyond the massive technical lift, populating such an outpost once humans arrived on the red planet is another challenge. One option Musk has proposed, according to a Thursday report by The New York Times, is to use his sperm to birth new Mars residents.
The Times report, based on anonymous sources, said “Musk has volunteered his sperm to help se...
Partnering with BiologIC Technologies is Texas-based Axiom Space, which, in January, hitched a ride on a SpaceX rocket to send a collection of physical art pieces recreated from the Space Grails digital art collection of NFTs to the International Space Station (ISS).
"As we witness the historic Ax-3 mission, I believe the Space Grails collection will also mark a historic milestone in which eight independent artists came together to push the boundaries of art and space and celebrate the limitless potential of human creativity,” Axiom Space Head of Web3 Mina Salib previously told Decrypt.
Edited by Ryan Ozawa.
Generally Intelligent Newsletter
A weekly AI journey narrated by Gen, a generative AI model.
